Glutathione is the body's most abundant internally produced antioxidant, and unlike vitamin C or vitamin E, it isn't something you primarily get from food. Your cells manufacture it themselves, continuously, from three simple amino acids. That fact turns out to be central to why glutathione levels fall with age and under stress: the decline isn't mainly about using it up faster than it can be replaced. It's about the body's own production line slowing down.
How the Body Makes Glutathione
Glutathione is synthesized inside cells from three amino acids, glutamate, cysteine, and glycine, through a two-step enzymatic process. The first and rate-limiting step is carried out by an enzyme called glutamate-cysteine ligase (GCL), which joins glutamate and cysteine together; the second step, carried out by glutathione synthetase, adds glycine to complete the molecule. Because GCL is the bottleneck step, how much of it is active, and how much of its raw material is available, largely determines how much glutathione a cell can produce at any given time.
Why Aging Slows Production
Research using stable-isotope tracer methods in older adults has found that glutathione deficiency in aging is driven primarily by decreased synthesis, not primarily by faster breakdown, and that this reduced synthesis traces back to limited availability of two of the three building blocks: glycine and cysteine. When researchers supplemented older adults with these two precursor amino acids for as little as two weeks, glutathione synthesis rates and concentrations were restored to levels seen in younger adults, and markers of oxidative stress dropped along with them. That finding points to a fairly specific mechanism: aging doesn't just wear down the glutathione already present, it constrains the raw materials and machinery needed to keep making more.
There's also a regulatory piece to this story. The GCL enzyme, along with a number of other antioxidant defenses, is controlled by a transcription factor called Nrf2, which normally ramps up antioxidant gene expression in response to oxidative stress, essentially telling cells to produce more glutathione when they're under attack. Research in aging liver tissue has found that Nrf2's transcriptional activity declines with age, meaning the signal that should be turning up glutathione production in response to oxidative stress becomes weaker over time. The practical effect is a kind of double bind: oxidative stress tends to rise with age, which is exactly when more glutathione is needed, but the cellular machinery that's supposed to respond to that rising stress by making more glutathione is itself becoming less responsive.
Why Stress Cuts Both Ways
Stress and glutathione have a more complicated relationship than a simple decline, because the direction of the effect depends heavily on how much stress and for how long. Mild, short-term stress generally increases glutathione levels, largely by activating the same GCL enzyme responsible for synthesis, which is part of a broader adaptive response researchers refer to as preconditioning: a small stressor prompts the cell to build up extra antioxidant defenses in case a bigger stressor follows. In this sense, brief stress can actually be a signal that temporarily strengthens the glutathione system rather than depleting it.
That protective response has limits, though. When stress is severe, prolonged, or chronic, the demand for glutathione to neutralize the resulting oxidative load can outpace the cell's ability to keep synthesizing more, particularly if precursor amino acids are already limited, as they tend to be with age. At that point, the same GCL-driven system that would normally increase output under mild stress instead runs into a ceiling, and glutathione concentrations fall rather than rise. This is consistent with the broader pattern seen in aging tissue: it isn't stress itself that depletes glutathione so much as it is a mismatch between elevated demand and a synthesis system that can no longer keep pace.
The Bigger Picture: The Free Radical Theory of Aging
This whole dynamic fits into a broader framework known as the free radical theory of aging, which proposes that age-related functional decline is driven in large part by the cumulative buildup of oxidative damage. Glutathione is the cell's principal low-molecular-weight antioxidant and a required co-substrate for several other antioxidant and detoxification enzymes, so a declining supply doesn't just remove one defense, it weakens several interconnected systems that depend on it. Research has found the evidence for glutathione loss with age to be especially strong in the brain, where it has been linked to increased vulnerability in neurons and implicated in conditions like Parkinson's disease, underscoring that this isn't a purely cosmetic or low-stakes decline.
The Bottom Line
Glutathione levels fall with age largely because the body's synthesis machinery slows down, driven by both a shortage of the precursor amino acids glycine and cysteine and a weakening of the Nrf2 signaling pathway that's supposed to ramp up production under stress. Short-term, mild stress can temporarily boost glutathione as part of a protective preconditioning response, but severe or chronic stress can overwhelm that same system, especially once age has already limited the raw materials available for synthesis. In both cases, the underlying story is less about glutathione being consumed too quickly and more about the production line itself becoming constrained, which is why interventions aimed at restoring precursor availability have shown some of the clearest results in the research to date.